Yang Shuofei, Zhang Lan, Liu Kai, Fan Xinxin, Ding Weiwei, He Changsheng, Wu Xingjiang, Li Jieshou
Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China; Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu Province, P. R. China.
Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China.
Ann Vasc Surg. 2016 Aug;35:88-97. doi: 10.1016/j.avsg.2016.02.019. Epub 2016 Jun 3.
Little data evaluate catheter-directed thrombolysis (CDT) therapy as a sequential treatment of emergent surgery for patients with acute superior mesenteric venous thrombosis (ASMVT). We compared the outcomes of ASMVT patients receiving CDT via superior mesenteric artery (SMA) with those who had systemic anticoagulation after emergent laparotomy.
A single-center retrospective study of ASMVT patients receiving emergent laparotomy from May 2012 to April 2014 was performed. Patients in group I had postoperative systemic anticoagulation and patients in group II underwent postoperative CDT. The demography, etiology, imaging features, clinical outcomes, and complications were compared. Moreover, univariate analysis was performed to identify confounding variables of 30-day mortality.
Thirty-two patients (20 males, mean age of 44.9 ± 10.6 years) were included, 17 in group I and 15 in group II. No significant differences of demographic data, etiology, baseline value, and perioperative comorbidity were found. The rate of complete thrombus removal was significantly higher in group II than group I (29.4% vs. 80.0%, P = 0.001). The second-look laparotomy and repeat bowel resection (58.8% vs. 13.3%, P = 0.002) were required in fewer patients in group II (20.0% vs. 70.6%, P = 0.001). The incidence of short-bowel syndrome (SBS; 41.2% vs. 6.7%, P = 0.001) and 30-day mortality (41.2% vs. 6.7%, P = 0.001) were lower in group II. The 1-year survival was also better in group II (52.9% vs. 93.3%, P = 0.014). The incidence of massive abdominal hemorrhage requiring blood transfusion and surgical intervention was 11.8% in group I and 20.0% in group II (P = 0.645). The age, serum D-dimer level, SBS, and postoperative CDT were significant risk factors of 30-day mortality in this study.
For ASMVT patients receiving emergent surgery and intraoperative thrombectomy, the algorithm with postoperative CDT via SMA is associated with more favorable clinical outcome compared with systemic anticoagulation.
很少有数据评估导管直接溶栓(CDT)疗法作为急性肠系膜上静脉血栓形成(ASMVT)患者紧急手术后的序贯治疗。我们比较了经肠系膜上动脉(SMA)接受CDT的ASMVT患者与紧急剖腹手术后接受全身抗凝治疗的患者的结局。
对2012年5月至2014年4月接受紧急剖腹手术的ASMVT患者进行单中心回顾性研究。I组患者术后接受全身抗凝治疗,II组患者术后接受CDT治疗。比较两组患者的人口统计学、病因、影像学特征、临床结局和并发症。此外,进行单因素分析以确定30天死亡率的混杂变量。
共纳入32例患者(20例男性,平均年龄44.9±10.6岁),I组17例,II组15例。两组患者的人口统计学数据、病因、基线值和围手术期合并症无显著差异。II组完全清除血栓的比例显著高于I组(29.4%对80.0%,P = 0.001)。II组需要二次剖腹手术和再次肠切除的患者较少(58.8%对13.3%,P = 0.002)(20.0%对70.6%,P = 0.001)。II组短肠综合征(SBS)的发生率(41.2%对6.7%,P = 0.001)和30天死亡率(41.2%对6.7%,P = 0.001)较低。II组的1年生存率也更高(52.9%对93.3%,P = 0.014)。I组需要输血和手术干预的大量腹腔内出血发生率为11.8%,II组为20.0%(P = 0.645)。年龄、血清D-二聚体水平、SBS和术后CDT是本研究中30天死亡率的显著危险因素。
对于接受紧急手术和术中取栓的ASMVT患者,与全身抗凝相比,术后经SMA进行CDT的治疗方案具有更有利的临床结局。